X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Sun Pharma Advanced Research Company Ltd.
BSE CODE: 532872   |   NSE CODE: SPARC   |   ISIN CODE : INE232I01014   |   01-Oct-2025 Hrs IST
BSE NSE
Rs. 132.25
2.95 ( 2.28% )
 
Prev Close ( Rs.)
129.30
Open ( Rs.)
131.60
 
High ( Rs.)
132.80
Low ( Rs.)
129.75
 
Volume
17189
Week Avg.Volume
20656
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 132.15
2.63 ( 2.03% )
 
Prev Close ( Rs.)
129.52
Open ( Rs.)
130.04
 
High ( Rs.)
132.80
Low ( Rs.)
129.11
 
Volume
193224
Week Avg.Volume
240278
 
52 WK High-Low Range(Rs.)
109.3
241
Particulars Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operational & Financial Ratios          
   Earnings Per Share (Rs)-10.64  -11.96  -6.86  -7.48  -5.77  
   CEPS(Rs)-10.30  -11.59  -6.50  -7.11  -5.35  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)-6.80  3.85  15.80  -7.47  -6.42  
   Tax Rate(%)0.00  0.00  0.00  0.00  0.00  
Margin Ratios          
   Core EBITDA Margin(%)-456.03  -534.50  -89.65  -136.07  -53.36  
   EBIT Margin(%)-468.63  -511.55  -90.02  -138.48  -55.54  
   Pre Tax Margin(%)-481.04  -513.74  -93.22  -148.19  -59.75  
   PAT Margin (%)-481.04  -513.74  -93.22  -148.19  -59.75  
   Cash Profit Margin (%)-465.95  -497.68  -88.29  -140.79  -55.43  
Performance Ratios          
   ROA(%)-84.65  -58.96  -40.10  -79.80  -60.18  
   ROE(%)0.00  -121.73  -143.72  0.00  0.00  
   ROCE(%)-321.18  -112.88  -69.44  -225.57  -254.10  
   Asset Turnover(x)0.18  0.11  0.43  0.54  1.01  
   Sales/Fixed Asset(x)0.47  0.51  1.71  1.07  1.96  
   Working Capital/Sales(x)-0.21  29.99  0.87  -1.37  -1.46  
Efficiency Ratios          
   Fixed Capital/Sales(x)2.12  1.97  0.58  0.93  0.51  
   Receivable days80.33  116.55  46.20  60.25  24.26  
   Inventory Days0.00  0.00  0.00  0.00  0.00  
   Payable days0  0  0  0  0  
Valuation Parameters          
   PER(x)0.00  0.00  0.00  0.00  0.00  
   PCE(x)-14.36  -31.93  -27.62  -41.77  -26.48  
   Price/Book(x)-21.77  96.16  11.36  -39.75  -22.07  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)70.51  157.49  23.92  59.34  15.55  
   EV/Core EBITDA(x)-15.55  -31.79  -28.11  -45.27  -30.37  
   EV/EBIT(x)-15.05  -30.79  -26.57  -42.85  -28.01  
   EV/CE(x)134.70  69.23  11.14  76.67  63.16  
   M Cap / Sales66.93  158.92  24.39  58.81  14.68  
Growth Ratio          
   Net Sales Growth(%)-5.00  -68.36  73.98  -45.74  229.31  
   Core EBITDA Growth(%)13.05  -84.23  -12.94  -38.85  56.85  
   EBIT Growth(%)12.97  -79.79  -13.09  -35.29  54.64  
   PAT Growth(%)11.05  -74.36  -9.43  -34.58  51.62  
   EPS Growth(%)11.05  -74.37  8.32  -29.71  51.62  
Financial Stability Ratios          
   Total Debt/Equity(x)-1.17  0.38  0.00  -0.37  -1.37  
   Current Ratio(x)0.07  1.01  2.54  0.42  0.26  
   Quick Ratio(x)0.07  1.01  2.54  0.42  0.26  
   Interest Cover(x)-37.76  -233.48  -28.15  -14.26  -13.19  
   Total Debt/Mcap(x)0.05  0.00  0.00  0.01  0.06